Genfit Stock

Genfit Current Assets

The Current Assets of Genfit (GNFT.PA) as of Aug 10, 2026 is 92.77 M EUR. In the previous year, Current Assets was 113.12 M EUR — a change of -17.99% (lower).

Current Assets

92.77 MEUR

YoY

-17.99%

Last updated:

Current Assets of Genfit is 2026 92.77 M EUR. Current Assets of Genfit was 2025 113.12 M EUR. It decreases by -17.99% lower compared to the previous year.
Access this data via the Eulerpool API

Genfit Stock analysis

What does Genfit do? Genfit SA is a French company specializing in the development of therapies for the treatment of liver diseases, specifically non-alcoholic steatohepatitis (NASH). The company was founded in 1999 and is headquartered in Loos, France. Genfit is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genfit stock

Current Assets of Genfit is 92.77 M EUR in 2026.

Current Assets of Genfit changed from 113.12 M EUR to 92.77 M EUR, representing a -17.99% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Genfit since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Genfit historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Genfit

All Key Metrics — Genfit